Ionis Pharmaceuticals | IONS - Cash And Equivalent


Ionis Pharmaceuticals reported $2.68B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 89.13M 3.58M Dec/2025
Alnylam Pharmaceuticals USD 1.66B 167M Dec/2025
Arrowhead Research USD 201.64M 112.94M Dec/2025
Astellas Pharma JPY 188.37B 8.51B Mar/2025
BioCryst Pharmaceuticals USD 84.08M 3.95M Sep/2025
BioMarin Pharmaceutical USD 1.31B 61.57M Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Exelixis USD 482.49M 106.19M Dec/2025
Halozyme Therapeutics USD 133.82M 285.84M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Moderna USD 2.6B 1.46B Dec/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Neurocrine Biosciences USD 713M 372.8M Dec/2025
Novartis USD 9.56B 2.9B Sep/2025
Omeros USD 1.9M 2.36M Jun/2025
OPKO Health USD 411.97M 144.69M Sep/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
PTC Therapeutics USD 984.65M 312.03M Dec/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 801.28M 188.2M Dec/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 202.51M 36.4M Sep/2025
Vertex Pharmaceuticals USD 6.61B 321.1M Dec/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025